Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial S Muruganandan, M Azzopardi, DB Fitzgerald, R Shrestha, BCH Kwan, ... The Lancet Respiratory Medicine 6 (9), 671-680, 2018 | 163 | 2018 |
Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery F Piccolo, N Pitman, R Bhatnagar, N Popowicz, NA Smith, B Brockway, ... Annals of the American Thoracic Society 11 (9), 1419-1425, 2014 | 135 | 2014 |
Intrapleural tissue plasminogen activator and deoxyribonuclease therapy for pleural infection F Piccolo, N Popowicz, D Wong, YCG Lee Journal of Thoracic Disease 7 (6), 999, 2015 | 100 | 2015 |
Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for pleural infection therapy project N Popowicz, O Bintcliffe, D De Fonseka, KG Blyth, NA Smith, F Piccolo, ... Annals of the American Thoracic Society 14 (6), 929-936, 2017 | 91 | 2017 |
Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study JP Corcoran, I Psallidas, S Gerry, F Piccolo, CF Koegelenberg, T Saba, ... European Respiratory Journal 56 (5), 2020 | 63 | 2020 |
Immediate effects of lumacaftor/ivacaftor administration on lung function in patients with severe cystic fibrosis lung disease N Popowicz, J Wood, A Tai, S Morey, S Mulrennan Journal of Cystic Fibrosis 16 (3), 392-394, 2017 | 40 | 2017 |
Bacteriology and clinical outcomes of patients with culture‐positive pleural infection in Western Australia: a 6‐year analysis F Brims, N Popowicz, A Rosenstengel, J Hart, A Yogendran, CA Read, ... Respirology 24 (2), 171-178, 2019 | 38 | 2019 |
Human pleural fluid is a potent growth medium for Streptococcus pneumoniae ND Popowicz, SM Lansley, HM Cheah, ID Kay, CF Carson, GW Waterer, ... PLoS One 12 (11), e0188833, 2017 | 26 | 2017 |
To be or not to be on CFTR modulators during pregnancy: Risks to be considered S Vekaria, N Popowicz, SW White, S Mulrennan Journal of Cystic Fibrosis 19 (2), e7-e8, 2020 | 19 | 2020 |
Alteplase Dose Assessment for Pleural infection Therapy (ADAPT) Study‐2: Use of 2.5 mg alteplase as a starting intrapleural dose N Popowicz, H Ip, EPM Lau, F Piccolo, K Dootson, C Yeoh, WY Phu, ... Respirology 27 (7), 510-516, 2022 | 15 | 2022 |
Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance N Popowicz, HM Cheah, C Gregory, A Miranda, IM Dick, YCG Lee, ... PLoS One 16 (4), e0250628, 2021 | 14 | 2021 |
A rapid, LC-MS/MS assay for quantification of piperacillin and tazobactam in human plasma and pleural fluid; application to a clinical pharmacokinetic study ND Popowicz, SJ O'Halloran, D Fitzgerald, YCG Lee, DA Joyce Journal of Chromatography B 1081, 58-66, 2018 | 14 | 2018 |
Steroid Therapy and Outcome of Parapneumonic Pleural Effusions (STOPPE): a pilot randomized clinical trial DB Fitzgerald, GW Waterer, C Budgeon, R Shrestha, ET Fysh, ... American Journal of Respiratory and Critical Care Medicine 205 (9), 1093-1101, 2022 | 13 | 2022 |
Steroid therapy and outcome of parapneumonic pleural effusions (STOPPE): Study protocol for a multicenter, double-blinded, placebo-controlled randomized clinical trial DB Fitzgerald, GW Waterer, CA Read, ET Fysh, R Shrestha, C Stanley, ... Medicine 98 (43), e17397, 2019 | 13 | 2019 |
Two sequential tPA/DNase courses for noncommunicating loculated collections in pleural infection N Popowicz, F Piccolo, R Shrestha, YCG Lee Respirology Case Reports 2 (2), 87-89, 2014 | 12 | 2014 |
Mepolizumab use in cystic fibrosis‐associated allergic bronchopulmonary aspergillosis M Boyle, S Mulrennan, S Morey, S Vekaria, N Popowicz, A Tai Respirology Case Reports 9 (1), e00696, 2021 | 11 | 2021 |
Preclinical assessment of adjunctive tPA and DNase for peritoneal dialysis associated peritonitis AL McGuire, SC Bennett, SM Lansley, ND Popowicz, ... PloS one 10 (3), e0119238, 2015 | 11 | 2015 |
An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection EPM Lau, M Eshraghi, K Dootson, C Yeoh, WY Phu, YCG Lee, ... ERJ Open Research 8 (1), 2022 | 10 | 2022 |
Pathogenesis of pleural infection: A complex warfare N Popowicz, S Idell, YCG Lee Respirology 23 (1), 8-9, 2018 | 8 | 2018 |
Pleural pharmacokinetics N Popowicz, B Sparling Textbook of Pleural Diseases, 104-121, 2016 | 7 | 2016 |